Novartis

Novartis

Community score

+1.35 -55
Industry: Biotechnology & Pharmaceuticals
Listing country: Switzerland
Year added: 2018

Novartis, a global healthcare company, was established on December 20, 1996, through the merger of Ciba-Geigy and Sandoz. With its headquarters situated in Basel, Switzerland, the company focuses on several key business segments. The Innovative Medicines division is responsible for the development and distribution of patented prescription drugs that address serious health issues including oncology, cardiology, immunology, and neurology. Among the most influential brands under this division are Cosentyx, which is utilized in the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis; Entresto, for heart failure; Gilenya, for multiple sclerosis; and Lucentis, targeting various eye diseases. Additionally, Tasigna and Gleevec are notable contributions to the treatment of chronic myeloid leukemia. Another central segment is Sandoz, the generics and biosimilars arm of Novartis, which provides a broad array of generic options, such as those for dermatology, respiratory conditions, ophthalmology, and oncology. The company's global reach is extensive, with a presence in over 155 countries. Novartis has a significant market in the United States and holds a robust position in Europe. It is also expanding in emerging markets across Asia and Latin America, where its products and services cater to diverse healthcare needs. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
My impact scoreBeta
List View
Novartis

Research and development (R&D) investments are crucial to developing diagnostics, drugs, and vaccines that improve & save people's lives1. Psoriasis is an incurable disease affecting 125 million (Mn) people, causing skin itchiness and irritation2....

Hajarat H. January 16th, 2024
40 ratings
Novartis

Around 2 billion (Bn) people worldwide lack access to essential medications1;p1. At least 10% of the household budget of over 800 million (Mn) people goes into healthcare expenditure, and 100 Mn people are pushed to extreme poverty due to unafford...

Manisha R. November 30th, 2023
24 ratings
Novartis

In order to ensure strong institutions and the well-being of society, governments spend a considerable amount of the state's budget on public goods and services, which are funded by taxes paid by individuals and corporations1. Corporate taxes acco...

Ifeoluwa I. November 7th, 2023
18 ratings
Novartis

Packaging waste leakage has significantly increased in recent years1, wherein 40% of plastic waste ends up in landfills1. Plastics can take 20 to 500 years to decompose and take around 450 years to break down fully2. Pharmaceutical waste includes ...

Rasheed S. September 7th, 2023
12 ratings
Novartis

Around 3.43 billion people are employed globally as of 20221. Job creation is vital for society, as well as for the economy2. It fuels economic growth as the spending of wages leads to a higher rate of consumer spending3. it reduces poverty as it ...

Muhammad Aqib A. August 30th, 2023
28 ratings
Novartis

Around 4 trillion m3 of freshwater is used worldwide every year1. Only 3% of the total available water on Earth is freshwater, and only 0.5% is for human consumption2. Around 20% of the total water consumption is used by industry3;p7. Companies sh...

Damola D. August 29th, 2023
14 ratings
Novartis

Racial discrimination negatively affects minorities' socio-economic status, mental health, and self-esteem1, 8. Minority underrepresentation in the workplace leads to discrimination, parting them at an economic disadvantage and vulnerability2. In ...

V S M. July 10th, 2023
20 ratings
Novartis

Women accounted for 47.7% of the global workforce1. As per the ILO's requirement, 40–60% representation of both genders is required to achieve gender parity2;pxii. Female underrepresentation negatively affects their earning negotiations, promoti...

Paul A. April 14th, 2023
20 ratings
Novartis

Greenhouse gases (GHGs) trap the Sun’s heat and cause a rise in temperature and sea level, extreme weather conditions, and climate change1. In 2021, global GHG emissions amounted to about 40.8 billion tonnes (t) of CO2e2. Industries must develop...

Paul A. April 11th, 2023
112 ratings
Novartis

Around 80% of wastewater produced globally is discharged into the environment without proper treatment1The pharmaceutical industry generates wastewater of complex composition, with a high level of organic matter, nitrogen (N), phosphorus (P), an...

Joy C. June 21st, 2023
42 ratings

Most negative / positive SDG

+2.72
-3.45